Each child is unique, and every cancer is different. As the Pediatric Cancer Genome Project continues to drive basic research on the genetics of cancer, St. Jude is launching an ambitious new program to apply its powerful technologies where they are needed most: the bedsides of our patients.
The vision of the new program is to use technology called genome sequencing to carefully scrutinize every one of the 3 billion letters of the genetic code of patients and their cancers. When analyzed with advanced computing technology, the results can be used to accurately identify a cancer and find its genetic vulnerabilities. These results can also show if the patient was born with an increased risk for cancer.
Bringing large-scale genome sequencing out of the research lab and into the clinic is a massive endeavor. Using the technology in patient care requires deep expertise, state-of-the-art facilities, and focused, mission-driven research, all major strengths of St. Jude.
This technology offers the promise of true precision medicine, in which treatment and long-term care can be tailored for each child.